Literature DB >> 13791298

Studies on the standardization of the intradermal test for the diagnosis of bilharziasis.

I G KAGAN, J PELLEGRINO, J M MEMORIA.   

Abstract

Entities:  

Keywords:  SCHISTOSOMIASIS/diagnosis; SERODIAGNOSIS

Mesh:

Year:  1961        PMID: 13791298     DOI: 10.4269/ajtmh.1961.10.200

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  8 in total

1.  Intradermal and fluorescent antibody tests on humans exposed to Schistosoma bovis cercariae from Sardinia.

Authors:  E H SADUN
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

2.  Anthelmintic therapy program in a school using two formulations of dithiazanine.

Authors:  M M BROOKE; F FEBLES; M BAZEMORE
Journal:  Public Health Rep       Date:  1961-11       Impact factor: 2.792

3.  A critical review of immunological methods for the diagnosis of bilharziasis.

Authors:  I G KAGAN; J PELLEGRINO
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

Review 4.  A review of serological tests for the diagnosis of hydatid disease.

Authors:  I G Kagan
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  Serologic diagnosis of schistosomiasis.

Authors:  I G Kagan
Journal:  Bull N Y Acad Med       Date:  1968-03

6.  Effect of praziquantel on certain immune responses of schistosomal Egyptian patients. II. Cell-mediated lymphoproliferative response.

Authors:  A E el-Bassiouny; Z A Shaker; A H el-Kalouby; E H el-Raziky
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

7.  Induction of cellular and humoral immunological responsiveness to a soluble cercarial antigen preparation from Schistosoma mansoni.

Authors:  S P Katz; D G Colley
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  Analysis of the intradermal response against a soluble cercarial antigenic preparation from Schistosoma mansoni.

Authors:  S P Katz; D G Colley
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.